Clinical efficacy in the budesonide / folmoterol for the COPD patients under using tiotropium.
Not Applicable
Recruiting
- Conditions
- COPD
- Registration Number
- JPRN-UMIN000011449
- Lead Sponsor
- Komaki City Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
(a) The patient who has BUD/FM in preliminary medication (b) The patient who has received hospitalization or the whole body, inhalation steroid medicine medication, and medication of the antibiotic within one month before the examination (c) The patient who has received the domiciliary oxygen therapy periodically (d) A patient with the past of bronchial asthma (e) The patient who has the past of hypersensitivity in BUD/FM (f) The patient who has chronic diseases, such as a lung, the heart, the kidney, liver, and blood (g) The patient who has an anamnesis of adrenal cortical insufficiency (h) The patient who judged test inclusion to be improper by an examination responsibility doctor's judgment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 6-minute walk distance and the amount of body activities
- Secondary Outcome Measures
Name Time Method mPEF and CAT